IDXG

Interpace Biosciences (IDXG)

Interpace Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IDXG

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/05/13	05 : 35	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDXG	Interpace Biosciences Inc
2023/05/13	05 : 24	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:IDXG	Interpace Biosciences Inc
2023/05/04	04 : 17	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:IDXG	Interpace Biosciences Inc
2023/04/29	05 : 20	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:IDXG	Interpace Biosciences Inc
2023/03/28	05 : 43	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDXG	Interpace Biosciences Inc
2023/03/28	05 : 40	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:IDXG	Interpace Biosciences Inc
2022/11/15	07 : 28	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:IDXG	Interpace Biosciences Inc
2022/11/15	07 : 25	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDXG	Interpace Biosciences Inc
2022/11/15	06 : 41	GlobeNewswire Inc.	Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results Sale of Pharma Significantly Improves Liquidity Resulting in Removal of Going Concern	NASDAQ:IDXG	Interpace Biosciences Inc
2022/11/05	05 : 34	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDXG	Interpace Biosciences Inc
2022/10/21	05 : 28	GlobeNewswire Inc.	Interpace Biosciences Announces New Real-world Data; Presented at the American Thyroid Association 2022 Annual Meeting	NASDAQ:IDXG	Interpace Biosciences Inc
2022/10/05	05 : 20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDXG	Interpace Biosciences Inc
2022/09/21	05 : 47	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:IDXG	Interpace Biosciences Inc
2022/09/21	05 : 37	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:IDXG	Interpace Biosciences Inc
2022/09/10	05 : 29	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:IDXG	Interpace Biosciences Inc
2022/09/08	05 : 46	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDXG	Interpace Biosciences Inc
2022/09/02	06 : 18	GlobeNewswire Inc.	Interpace Biosciences Announces New Clinical Validation Data; Diagnostic Accuracy Significantly Improved	NASDAQ:IDXG	Interpace Biosciences Inc
2022/09/01	06 : 30	GlobeNewswire Inc.	Interpace Biosciences Completes Sale of Its Pharma Services Business to Flagship Biosciences, Inc.	NASDAQ:IDXG	Interpace Biosciences Inc
2022/08/16	06 : 46	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDXG	Interpace Biosciences Inc
2022/08/16	05 : 05	GlobeNewswire Inc.	Interpace Biosciences Announces Second Quarter 2022 Financial and Business Results and New Clinical Validation Data; Diagnostic Accuracy Significantly Improved	NASDAQ:IDXG	Interpace Biosciences Inc
2022/05/17	06 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDXG	Interpace Biosciences Inc
2022/05/17	05 : 51	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:IDXG	Interpace Biosciences Inc
2022/05/17	05 : 15	GlobeNewswire Inc.	Interpace Biosciences Announces First Quarter 2022 Financial and Business Results	NASDAQ:IDXG	Interpace Biosciences Inc
2022/05/11	21 : 30	GlobeNewswire Inc.	Miroculus to Optimize Automated Next Generation Sequencing Library Preparation with Interpace Diagnostics and Twist Bioscience	NASDAQ:IDXG	Interpace Biosciences Inc
2022/05/11	05 : 33	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDXG	Interpace Biosciences Inc
2022/05/02	19 : 11	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:IDXG	Interpace Biosciences Inc
2022/04/15	05 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDXG	Interpace Biosciences Inc
2022/04/08	19 : 15	TipRanks	Analysts Offer Insights on Healthcare Companies: Interpace Diagnostics Group (OtherIDXG) and Biogen (BIIB)	NASDAQ:IDXG	Interpace Biosciences Inc
2022/04/01	05 : 44	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IDXG	Interpace Biosciences Inc
2022/04/01	05 : 15	GlobeNewswire Inc.	Interpace Biosciences Announces Full Year and Fourth Quarter 2021 Financial and Business Results	NASDAQ:IDXG	Interpace Biosciences Inc